Li

Li Ma is a Senior Scientific Chemist at XingImaging, LLC, overseeing the development and production of radiopharmaceuticals while ensuring GMP and GxP compliance. With over eight years of experience in radiopharmaceutical development and preclinical evaluation, Li has worked extensively with various radionuclides and has a strong background in nuclear medicine imaging and therapy. Li earned a Ph.D. in Radiochemistry from the University of Missouri-Columbia, where they developed potential radiopharmaceutical candidates and taught advanced radiochemistry courses. Previous roles include postdoctoral research at Harvard Medical School and Massachusetts General Hospital and study director positions at Invicro and Perceptive Inc.